News
July 17, 2020

Regenstrief research scientist chosen as co-director of Indiana CTSI

Regenstrief Institute research scientist Sarah E. Wiehe, M.D., MPH, will co-lead the Indiana Clinical and Translational Sciences Institute (CTSI) along with Sharon M. Moe, M.D. Indiana CTSI is focused on improving health in Indiana through a research partnership among the state’s leading research universities of Indiana University (IU), Purdue University and the University of Notre Dame.

Dr. Sharon Moe and Dr. Sarah Wiehe to lead Indian CTSI
Dr. Sharon Moe (left) and Dr. Sarah Wiehe (right)

The co-leaders are splitting their leadership responsibilities across the translational research spectrum. Dr. Moe is directing the earlier stages of research as it advances from the lab to the patient, and Dr. Wiehe is focusing her attention on the later phases, directing research from the patient to the general population.

Dr. Wiehe is a pediatrician and public health researcher. Her research focuses on how poverty, associated social determinants of health and context influence health-risk behaviors and outcomes for children, adolescents and young adults. She leverages existing data to identify mechanisms and opportunities for intervention to improve health among vulnerable populations.

She has spent six years as director of the Community Health Partnerships program of the Indiana CTSI. She is carrying that experience into her new position by sharing research from the Indiana CTSI on a national scale.

Dr. Wiehe is associate dean for community and translational research at Indiana University School of Medicine and an associate professor of pediatrics.

Dr. Wiehe and Dr. Moe are taking over for Indiana CTSI founding director Anantha Shekhar, MD, PhD, who – after 36 years of service – retired as IU Distinguished Professor Emeritus.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Regenstrief Institute is celebrating 50 years of healthcare innovation. Sam Regenstrief, a successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About Indiana CTSI

The Indiana Clinical and Translational Sciences Institute (CTSI) was founded in 2008 by Anantha Shekhar, M.D., PhD. Recognized as a statewide institute supported by a Clinical and Translational Science Award from the National Institutes of Health’s (NIH) and the National Center for Advancing Translational Science.

Indiana CTSI has research partnerships with Indiana University, Purdue University, and the University of Notre Dame which also includes life sciences, businesses and community organizations. Furthermore, Indiana CTSI engages with the public at every level of research from basic science to patient care.

Related News

Kathleen Unroe, M.D.

Barriers to Discharge for Nursing Home Residents With Serious Mental Illness

Published in the JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Kathleen T. Unroe,

Validation of a MIND diet screener in older adults

Published in Alzheimer’s & Dementia Journal. Here is a link to the article. Regenstrief Institute author: Daniel O. Clark,

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

INDIANAPOLIS — Researchers from the Fairbanks School of Public Health at Indiana University Indianapolis have launched a first-of-its-kind study

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Findings support longer-duration or targeted approaches A multi-center randomized controlled trial with critically ill adults aged 50 years and